Clinical Trial Detail

NCT ID NCT03286296
Title LZM009 to Treat Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Livzon Pharmaceutical Group Inc.
Indications

Advanced Solid Tumor

non-small cell lung carcinoma

Therapies

LZM009

Age Groups: senior adult

Additional content available in CKB BOOST